Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 3, 2025 • 4:01 PM ET
As of January 3, 2025 • 4:01 PM ET
Date/Time | Source | News Release |
---|---|---|
11/27/2024 04:31 AM EST | US Earnings Reports | Expected earnings - Milestone Pharmaceuticals Inc. |
11/19/2024 09:55 AM EST | Zacks | After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright |
11/12/2024 05:09 PM EST | SeekingAlpha | Milestone Pharmaceuticals files for mixed shelf offering |
11/12/2024 10:31 AM EST | SeekingAlpha | Milestone Pharmaceuticals GAAP EPS of -$0.14 |
08/22/2024 03:12 PM EDT | SeekingAlpha | Milestone wins Buy at Rodman & Renshaw on potential Cardamyst approval |
08/09/2024 06:17 AM EDT | SeekingAlpha | Milestone Pharmaceuticals GAAP EPS of -$0.14 |
05/16/2024 12:00 PM EDT | Zacks | Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know |
05/13/2024 08:42 AM EDT | SeekingAlpha | Milestone Pharmaceuticals GAAP EPS of -$0.21 beats by $0.05 |
05/10/2024 05:38 AM EDT | US Earnings Reports | Expected earnings - Milestone Pharmaceuticals Inc. |
03/22/2024 05:36 AM EDT | US Earnings Reports | Expected earnings - Milestone Pharmaceuticals Inc. |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.